Vivos Therapeutics, Inc. (VVOS)
NASDAQ·Healthcare·Medical - Devices
$0.86
-0.50%
Mkt Cap $7.83M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q2 2026 Apr 15, 2026 | $7.10M | $3.82M | -46.13% | -$0.49 | -$0.58 | -17.17% | — | — |
| Q4 2025 Nov 19, 2025 | $7.10M | $6.78M | -4.42% | -$0.53 | -$0.49 | +7.55% | — | — |
| Q3 2025 Aug 19, 2025 | $3.65M | $3.82M | +4.56% | -$0.27 | -$0.55 | -103.70% | — | — |
| Q2 2025 May 15, 2025 | $3.67M | $3.02M | -17.74% | -$0.44 | -$0.45 | -2.27% | — | — |
| Q1 2025 Mar 31, 2025 | $3.89M | $3.70M | -4.82% | -$0.43 | -$0.28 | +34.88% | — | — |
| Q4 2024 Nov 14, 2024 | $3.89M | $3.86M | -0.65% | -$0.70 | -$0.40 | +42.86% | — | — |
| Q3 2024 Aug 14, 2024 | $3.60M | $4.05M | +12.61% | -$1.05 | -$0.60 | +42.86% | — | — |
| Q2 2024 May 14, 2024 | $3.41M | $3.42M | +0.26% | -$1.17 | -$1.63 | -39.32% | — | — |
| Q1 2024 Mar 28, 2024 | $3.41M | $3.25M | -4.75% | -$1.90 | -$3.05 | -60.53% | — | — |
| Q4 2023 Nov 14, 2023 | $4.50M | $3.30M | -26.64% | -$3.12 | -$1.75 | +43.91% | — | — |
| Q3 2023 Aug 16, 2023 | $4.14M | $3.40M | -18.00% | -$3.75 | -$3.75 | +0.00% | — | — |
| Q2 2023 Jun 8, 2023 | $4.15M | $3.86M | -7.06% | -$4.25 | -$5.00 | -17.65% | — | — |
| Q1 2023 Mar 30, 2023 | $4.25M | $3.95M | -6.97% | -$5.50 | -$5.00 | +9.09% | — | — |
| Q4 2022 Dec 20, 2022 | $3.72M | $4.25M | +14.10% | -$0.28 | -$8.25 | -2846.43% | — | — |
| Q4 2022 Nov 25, 2022 | — | $3.46M | — | — | -$4.95 | — | — | — |
| Q3 2022 Aug 23, 2022 | $3.81M | $4.18M | +9.82% | — | -$8.27 | — | — | — |
| Q2 2022 May 16, 2022 | $4.44M | $4.39M | -1.07% | -$7.25 | -$6.50 | +10.34% | — | — |
| Q4 2021 Nov 15, 2021 | $4.50M | $4.55M | +1.02% | -$4.00 | -$6.50 | -62.50% | — | — |
| Q3 2021 Aug 12, 2021 | $4.50M | $4.50M | -0.01% | -$4.00 | -$4.75 | -18.75% | — | — |
| Q2 2021 May 17, 2021 | — | $3.45M | — | -$4.25 | -$4.75 | -11.76% | — | — |